首页> 美国卫生研究院文献>other >Human white adipose tissue vasculature contains endothelial colony-forming cells with robust in vivo vasculogenic potential
【2h】

Human white adipose tissue vasculature contains endothelial colony-forming cells with robust in vivo vasculogenic potential

机译:人白色脂肪组织的脉管系统包含具有强大的体内血管生成潜力的内皮集落形成细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Blood-derived endothelial colony-forming cells (ECFCs) have robust vasculogenic potential that can be exploited to bioengineer long-lasting human vascular networks in vivo. However, circulating ECFCs are exceedingly rare in adult peripheral blood. Because the mechanism by which ECFCs are mobilized into circulation is currently unknown, the reliability of peripheral blood as a clinical source of ECFCs remains a concern. Thus, there is a need to find alternative sources of autologous ECFCs. Here we aimed to determine whether ECFCs reside in the vasculature of human white adipose tissue (WAT) and to evaluate if WAT-derived ECFCs (watECFCs) have equal clinical potential to blood-derived ECFCs. We isolated the complete endothelial cell (EC) population from intact biopsies of normal human subcutaneous WAT by enzymatic digestion and selection of CD31+ cells. Subsequently, we extensively compared WAT-derived EC phenotype and functionality to bonafide ECFCs derived from both umbilical cord blood and adult peripheral blood. We demonstrated that human WAT is indeed a dependable source of ECFCs with indistinguishable properties to adult peripheral blood ECFCs, including hierarchical clonogenic ability, large expansion potential, stable endothelial phenotype, and robust in vivo blood vessel-forming capacity. Considering the unreliability and low rate of occurrence of ECFCs in adult blood and that biopsies of WAT can be obtained with minimal intervention in an ambulatory setting, our results indicate WAT as a more practical alternative to obtain large amounts of readily available autologous ECFCs for future vascular cell therapies.
机译:血液来源的内皮集落形成细胞(ECFC)具有强大的血管生成潜力,可用于体内生物工程化长效人类血管网络。但是,循环的ECFC在成人外周血中极为罕见。由于目前尚不清楚使ECFCs进入循环的机制,因此外周血作为ECFCs临床来源的可靠性仍然值得关注。因此,需要寻找自体ECFC的替代来源。在这里,我们旨在确定ECFC是否存在于人类白色脂肪组织(WAT)的脉管系统中,并评估WAT衍生的ECFC(watECFC)是否具有与血液衍生的ECFC相等的临床潜能。我们通过酶消化和选择CD31 + 细胞从正常人皮下WAT完整活检组织中分离出完整的内皮细胞(EC)。随后,我们广泛比较了WAT衍生的EC表型和功能与衍生自脐带血和成人外周血的纯正ECFC的比较。我们证明了人类WAT确实是ECFC的可靠来源,其与成人外周血ECFC的特性没有明显区别,包括分级克隆能力,大的扩增潜力,稳定的内皮表型和强大的体内血管形成能力。考虑到成人血液中ECFC的不可靠和低发生率,并且可以在非卧床环境中以最少的干预获得WAT的活检,我们的结果表明WAT是一种更实用的选择,可以为将来的血管获得大量易得的自体ECFC细胞疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号